Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 219

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study

Open access
Stewardson, Andrew J, Marimuthu, Kalisvar, Sengupta, Sharmila, Allignol, Arthur, El-Bouseary, Maisra, Carvalho, Maria J, Hassan, Brekhna, Delgado-Ramirez, Monica A, Arora, Anita, Bagga, Ruchika, Owusu-Ofori, Alex K, Ovosi, Joseph O, Aliyu, Shamsudin, Saad, Hala, Kanj, Souha S, Khanal, Basudha, Bhattarai, Balkrishna, Saha, Samir K, Uddin, Jamal, Barman, Purabi, Sharma, Latika, El-Banna, Tarek, Zahra, Rabaab, Saleemi, Mansab Ali, Kaur, Amarjeet, Iregbu, Kenneth, Uwaezuoke, Nkolika SC, Abi Hanna, Pierre, Feghali, Rita, Correa, Ana L, Munera, Maria I, Le, Thi Anh Thu, Tran, Thi Thanh Nga, Phukan, Chimanjita, Phukan, Chiranjita, Valderrama-Beltrán, Sandra L, Alvarez-Moreno, Carlos, Walsh, Timothy R, Harbarth, Stephan · 2019 · The Lancet Infectious Diseases

Abstract

BACKGROUND Low-income and middle-income countries (LMICs) are under-represented in reports on the burden of antimicrobial resistance. We aimed to quantify the clinical effect of carbapenem resistance on mortality and length of hospital stay among inpatients in LMICs with a bloodstream infection due to Enterobacteriaceae. METHODS The PANORAMA study was a multinational prospective cohort study at tertiary hospitals in Bangladesh, Colombia, Egypt, Ghana, India, Lebanon, Nepal, Nigeria, Pakistan, and Vietnam, recruiting consecutively diagnosed patients with carbapenem-susceptible Enterobacteriaceae (CSE) and carbapenem-resistant Entero-bacteriaceae (CRE) bloodstream infections. We excluded patients who had previously been enrolled in the study and those not treated with curative intent at the time of bloodstream infection onset. There were no age restrictions. Central laboratories in India and the UK did confirmatory testing and molecular characterisation, including strain typing. We applied proportional subdistribution hazard models with inverse probability weighting to estimate the effect of carbapenem resistance on probability of discharge alive and in-hospital death, and multistate modelling for excess length of stay in hospital. All patients were included in the analysis. FINDINGS Between Aug 1, 2014, and June 30, 2015, we recruited 297 patients from 16 sites in ten countries: 174 with CSE bloodstream infection and 123 with CRE bloodstream infection. Median age was 46 years (IQR 15-61). Crude mortality was 20% (35 of 174 patients) for patients with CSE bloodstream infection and 35% (43 of 123 patients) for patients with CRE bloodstream infection. Carbapenem resistance was associated with an increased length of hospital stay (3·7 days, 95% CI 0·3-6·9), increased probability of in-hospital mortality (adjusted subdistribution hazard ratio 1·75, 95% CI 1·04-2·94), and decreased probability of discharge alive (0·61, 0·45-0·83). Multilocus sequence typing showed various clades, with marginal overlap between strains in the CRE and CSE clades. INTERPRETATION Carbapenem resistance is associated with increased length of hospital stay and mortality in patients with bloodstream infections in LMICs. These data will inform global estimates of the burden of antimicrobial resistance and reinforce the need for better strategies to prevent, diagnose, and treat CRE infections in LMICs. FUNDING bioMérieux.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(18)30792-8

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 219

Metadata

Authors
Stewardson, A. J., Marimuthu, K., Sengupta, S., Allignol, A., El-Bouseary, M., Carvalho, M. J., Hassan, B., Delgado-Ramirez, M. A., Arora, A., Bagga, R., Owusu-Ofori, A. K., Ovosi, J. O., Aliyu, S., Saad, H., Kanj, S. S., Khanal, B., Bhattarai, B., Saha, S. K., Uddin, J., Barman, P., Sharma, L., El-Banna, T., Zahra, R., Saleemi, M. A., Kaur, A., Iregbu, K., Uwaezuoke, N. S., Abi Hanna, P., Feghali, R., Correa, A. L., Munera, M. I., Le, T. A. T., Tran, T. T. N., Phukan, C., Phukan, C., Valderrama-Beltrán, S. L., Alvarez-Moreno, C., Walsh, T. R., & Harbarth, S.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2019-06
Volume
19
Issue
6
Pages
601-610
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2943815887
Cited by
219
References
7
FWCI
8.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. https://app.cochat.ai/papers/10.1016/s1473-3099(18)30792-8
The paper
Stewardson, A. J., Marimuthu, K., Sengupta, S., Allignol, A., El-Bouseary, M., Carvalho, M. J., Hassan, B., Delgado-Ramirez, M. A., Arora, A., Bagga, R., Owusu-Ofori, A. K., Ovosi, J. O., Aliyu, S., Saad, H., Kanj, S. S., Khanal, B., Bhattarai, B., Saha, S. K., Uddin, J., . . . Harbarth, S. (2019). Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(18)30792-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.